Literature DB >> 25733525

Cause of Death in Patients with Reduced Kidney Function.

Stephanie Thompson1, Matthew James2, Natasha Wiebe1, Brenda Hemmelgarn2, Braden Manns2, Scott Klarenbach1, Marcello Tonelli3.   

Abstract

Information on common causes of death in people with CKD is limited. We hypothesized that, as eGFR declines, cardiovascular mortality and mortality from infection account for increasing proportions of deaths. We calculated eGFR using the CKD Epidemiology Collaboration equation for residents of Alberta, Canada who died between 2002 and 2009. We used multinomial logistic regression to estimate unadjusted and age- and sex-adjusted differences in the proportions of deaths from each cause according to the severity of CKD. Cause of death was classified as cardiovascular, infection, cancer, other, or not reported using International Classification of Diseases codes. Among 81,064 deaths, the most common cause was cancer (31.9%) followed by cardiovascular disease (30.2%). The most common cause of death for those with eGFR≥60 ml/min per 1.73 m(2) and no proteinuria was cancer (38.1%); the most common cause of death for those with eGFR<60 ml/min per 1.73 m(2) was cardiovascular disease. The unadjusted proportion of patients who died from cardiovascular disease increased as eGFR decreased (20.7%, 36.8%, 41.2%, and 43.7% of patients with eGFR≥60 [with proteinuria], 45-59.9, 30-44.9, and 15-29.9 ml/min per 1.73 m(2), respectively). The proportions of deaths from heart failure and valvular disease specifically increased with declining eGFR along with the proportions of deaths from infectious and other causes, whereas the proportion of deaths from cancer decreased. In conclusion, we found an inverse association between eGFR and specific causes of death, including specific types of cardiovascular disease, infection, and other causes, in this cohort.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; GFR; cardiovascular disease; epidemiology and outcomes; mortality

Mesh:

Year:  2015        PMID: 25733525      PMCID: PMC4587695          DOI: 10.1681/ASN.2014070714

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Problems with proper completion and accuracy of the cause-of-death statement.

Authors:  A E Smith Sehdev; G M Hutchins
Journal:  Arch Intern Med       Date:  2001-01-22

Review 2.  Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.

Authors:  Gérard M London; Sylvain J Marchais; Alain P Guérin; Fabien Métivier
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-11       Impact factor: 2.894

Review 3.  Chronic kidney disease and mortality risk: a systematic review.

Authors:  Marcello Tonelli; Natasha Wiebe; Bruce Culleton; Andrew House; Chris Rabbat; Mei Fok; Finlay McAlister; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

4.  Kidney function as a predictor of noncardiovascular mortality.

Authors:  Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

5.  Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival.

Authors:  Berthus G Loef; Anne H Epema; Ton D Smilde; Robert H Henning; Tjark Ebels; Gerjan Navis; Coen A Stegeman
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

6.  Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

Authors:  Janet E Hux; Frank Ivis; Virginia Flintoft; Adina Bica
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

7.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

8.  Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function.

Authors:  Charuhas V Thakar; Sarah Worley; Susana Arrigain; Jean-Pierre Yared; Emil P Paganini
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 10.  Association of frailty and physical function in patients with non-dialysis CKD: a systematic review.

Authors:  Simon R Walker; Kamalpreet Gill; Kerry Macdonald; Paul Komenda; Claudio Rigatto; Manish M Sood; Clara J Bohm; Leroy J Storsley; Navdeep Tangri
Journal:  BMC Nephrol       Date:  2013-10-22       Impact factor: 2.388

View more
  149 in total

Review 1.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

2.  An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.

Authors:  Pierre Delanaye; Richard J Glassock; Hans Pottel; Andrew D Rule
Journal:  Clin Biochem Rev       Date:  2016-02

3.  Not All Deaths in CKD Are from a Broken Heart.

Authors:  Germaine Wong; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2015-06-04       Impact factor: 10.121

4.  RECENT ADVANCES IN UNDERSTANDING THE CIRCADIAN CLOCK IN RENAL PHYSIOLOGY.

Authors:  G Ryan Crislip; Sarah H Masten; Michelle L Gumz
Journal:  Curr Opin Physiol       Date:  2018-06-20

5.  Uncoded chronic kidney disease in primary care: a cross-sectional study of inequalities and cardiovascular disease risk management.

Authors:  Mariam Molokhia; Grace N Okoli; Patrick Redmond; Elham Asgari; Catriona Shaw; Peter Schofield; Mark Ashworth; Stevo Durbaba; Dorothea Nitsch
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

6.  Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.

Authors:  Milica Bozic; Angels Betriu; Marcelino Bermudez-Lopez; Alberto Ortiz; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

7.  The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study.

Authors:  Valeria M Saglimbene; Germaine Wong; Jonathan C Craig; Marinella Ruospo; Suetonia C Palmer; Katrina Campbell; Vanessa Garcia-Larsen; Patrizia Natale; Armando Teixeira-Pinto; Juan-Jesus Carrero; Peter Stenvinkel; Letizia Gargano; Angelo M Murgo; David W Johnson; Marcello Tonelli; Rubén Gelfman; Eduardo Celia; Tevfik Ecder; Amparo G Bernat; Domingo Del Castillo; Delia Timofte; Marietta Török; Anna Bednarek-Skublewska; Jan Duława; Paul Stroumza; Susanne Hoischen; Martin Hansis; Elisabeth Fabricius; Paolo Felaco; Charlotta Wollheim; Jörgen Hegbrant; Giovanni F M Strippoli
Journal:  J Am Soc Nephrol       Date:  2018-04-25       Impact factor: 10.121

Review 8.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

Review 9.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

10.  Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Authors:  Andreas Pasch; Geoffrey A Block; Matthias Bachtler; Edward R Smith; Wilhelm Jahnen-Dechent; Spyridon Arampatzis; Glenn M Chertow; Patrick Parfrey; Xiaoye Ma; Juergen Floege
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.